Creative Biolabs-Immuno-oncology

Anti-CCR6 (clone R6Z1G2E) SynExpress E1-Cy3-I4-X Modified CD8+ T cells (CAT#: ITS-1224-CR334)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR6 (clone R6Z1G2E). We employs the Lentivirus (EF1α-Cy3-IL-4-XbaI) vector components and the SynExpress system of the Exons Knockout/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CCR6
Clone
R6Z1G2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
IL-4
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.